← Leaderboards
Wilma J Lim
University Of North Carolina Chapel Hill
$2,704,196
Attributed
$2,704,196
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,704,196 · 5
By mechanism
M01$2,704,196 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Charles Michael Van Der Horst$17,688,631
- Annelies Van Rie$7,008,011
- Diana O. Perkins$14,499,789
- Marsha L Davenport$2,251,570
- Ian J Grimm$676,049
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchAids TherapyHuman Therapy EvaluationHiv InfectionsCombination ChemotherapyDrug Screening /EvaluationPediatric AidsPharmacokineticsZidovudineHuman Pregnant SubjectInfant Human (0-1 Year)ChemopreventionVertical TransmissionAids Education /PreventionHuman Immunodeficiency VirusAntiaids AgentChild (0-11)Adolescence (12-20)Antiviral AgentsPlacental TransferAntiviral AntibodyCase HistoryCognition
Grant awards (32)
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$190,747
M01 · FY2002 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$190,747
M01 · FY2002 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$190,747
M01 · FY2002 · RR
SAFETY/EFFICACY OF COMBINATION 1592U89/ZDV/3TC VERSUS ZDV/3TC IN HIV CHILDREN$190,747
M01 · FY2002 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$294,555
M01 · FY2001 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$294,555
M01 · FY2001 · RR
SAFETY/EFFICACY OF COMBINATION 1592U89/ZDV/3TC VERSUS ZDV/3TC IN HIV CHILDREN$294,555
M01 · FY2001 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$294,555
M01 · FY2001 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$190,747
M01 · FY2001 · RR
SAFETY/EFFICACY OF COMBINATION 1592U89/ZDV/3TC VERSUS ZDV/3TC IN HIV CHILDREN$190,747
M01 · FY2001 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$190,747
M01 · FY2001 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$190,747
M01 · FY2001 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$0
M01 · FY2000 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$0
M01 · FY2000 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$0
M01 · FY2000 · RR
NEVIRAPINE IN MATERNAL FETAL TRANSMISSION IN PREGNANT HIV WOMEN$0
M01 · FY2000 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$0
M01 · FY2000 · RR
ANTIRETROVIRAL MANAGEMENT FOR PEDIATRIC HIV PATIENTS$0
M01 · FY2000 · RR
ANTIRETROVIRAL MANAGEMENT FOR PEDIATRIC HIV PATIENTS$0
M01 · FY2000 · RR
ANTIRETROVIRAL MANAGEMENT FOR PEDIATRIC HIV PATIENTS$0
M01 · FY2000 · RR
ANTIRETROVIRAL MANAGEMENT FOR PEDIATRIC HIV PATIENTS$0
M01 · FY2000 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$0
M01 · FY2000 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$0
M01 · FY2000 · RR
HIVIG MATERNAL FETAL TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS$0
M01 · FY2000 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$0
M01 · FY2000 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$0
M01 · FY2000 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$0
M01 · FY2000 · RR
PEDIATRIC LATE OUTCOME PROTOCOL OF HIV (ACTG 219)$0
M01 · FY2000 · RR
COMBINATION OF 1592U89/ZDV/3TC VS ZDV/3TC/1294H IN HIV CHILDREN$0
M01 · FY2000 · RR
COMBINATION OF 1592U89/ZDV/3TC VS ZDV/3TC/1294H IN HIV CHILDREN$0
M01 · FY2000 · RR
COMBINATION OF 1592U89/ZDV/3TC VS ZDV/3TC/1294H IN HIV CHILDREN$0
M01 · FY2000 · RR
COMBINATION OF 1592U89/ZDV/3TC VS ZDV/3TC/1294H IN HIV CHILDREN$0
M01 · FY2000 · RR